P6 Phylogenetic clustering of recent hepatitis C virus infection between 2004 and 2015

by S.R. Bartlett, T. Applegate, B. Jacka, F. Lamoury, R. Bull, M. Danta, D. Bradshaw, A.R. Lloyd, M. Hellard, G.J. Dore, G.V. Matthews, J. Grebely
Published 2017-08-01

O7 Moving towards HCV elimination in HIV/HCV co- infection in Australia following universal access to interferon-free therapy

by Marianne Martinello, Gregory J. Dore, Rohan I. Bopage, Robert Finlayson, David Baker, Mark Bloch, Ecaterina Filep, Jasmine Skurowski, Lanni Lin, Francois Lamoury, Sofia Bartlett, Tanya Applegate, Margaret Hellard, Gail V. Matthews
Published 2017-08-01

P10 Injecting risk behaviours among people who inject drugs in an Australian prison setting, 2005–2014: the HITS-p study

by E. Cunningham, J. Amin, N.A. Bretana, F. Luciani, L. Degenhardt, S. Larney, B. Hajarizadeh, G.J. Dore, A. Lloyd, J. Grebely
Published 2017-08-01

P4 Acceptability of point of care finger-stick and venepuncture hepatitis C virus testing among people who inject drugs and homeless people

by S. Bajis, F. Lamoury, T.L. Applegate, L. Maher, C. Treloar, Y. Mowat, M. Schulz, B. Hajarizadeh, A. Marshall, E. Cunningham, V. Cock, N. Ezard, C. Gorton, J. Hayllar, J. Smith, G.J. Dore, J. Grebely
Published 2017-08-01

O6 Incidence of hepatitis C virus infection in two maximum-security prisons in New South Wales, Australia: the StoP-C study

by B. Hajarizadeh, J. Grebely, M. Byrne, P. Marks, J. Amin, T. Butler, P. Vickerman, N.K. Martin, J.G. McHutchison, D.M. Brainard, C. Treloar, A.R. Lloyd, G.J. Dore
Published 2017-08-01

P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia

by B. Hajarizadeh, J. Grebely, G.V. Matthews, M. Martinello, G.J. Dore
Published 2017-08-01

Long-term persistence of RBD+ memory B cells encoding neutralizing antibodies in SARS-CoV-2 infection

by Arunasingam Abayasingam, Harikrishnan Balachandran, David Agapiou, Mohamed Hammoud, Chaturaka Rodrigo, Elizabeth Keoshkerian, Hui Li, Nicholas A. Brasher, Daniel Christ, Romain Rouet, Deborah Burnet, Branka Grubor-Bauk, William Rawlinson, Stuart Turville, Anupriya Aggarwal, Alberto Ospina Stella, Christina Fichter, Fabienne Brilot, Michael Mina, Jeffrey J. Post, Bernard Hudson, Nicky Gilroy, Dominic Dwyer, Sarah C. Sasson, Fiona Tea, Deepti Pilli, Anthony Kelleher, Nicodemus Tedla, Andrew R. Lloyd, Marianne Martinello, Rowena A. Bull
Published 2021-04-01

O12 Australia could meet the WHO HCV elimination targets if the current rollout of DAA treatment is continued

by A.J. Kwon, G.J. Dore, J. Grebely, B. Hajarizadeh, R. Guy, E.B. Cunningham, C. Estes, H. Razavi, R.T. Gray
Published 2017-08-01

O23 Characterisation of populations with hepatitis C to improve access to antiviral therapy programs: a population-based linkage study

by M. Alavi, J. Amin, J. Grebely, M.G. Law, N.Z. Janjua, M. Krajden, B. Hajarizadeh, J. George, G.V. Matthews, S. Larney, L. Degenhardt, G.J. Dore
Published 2017-08-01

O13 Efficacy and safety of sofosbuvir/velpatasvir in people with chronic hepatitis C virus infection and recent injecting drug use: the SIMPLIFY study

by J. Grebely, O. Dalgard, B. Conway, E. Cunningham, P. Bruggmann, B. Hajarizadeh, J. Amin, P. Marks, S. Quiene, T.L. Applegate, T. Swan, J. Byrne, M. Lacalamita, A. Dunlop, J. Bruneau, M.E. Hellard, G.V. Matthews, J. Powis, D. Shaw, M.C. Thurnheer, M. Weltman, I. Kronborg, C. Cooper, J.J. Feld, C. Fraser, A. Litwin, J. Dillon, P. Read, E. Gane, G.J. Dore
Published 2017-08-01

HIV treatment regimens and adherence to national guidelines in Australia: an analysis of dispensing data from the Australian pharmaceutical benefits scheme

by Nila J. Dharan, Tomas Radovich, Samuel Che, Kathy Petoumenos, Prabhjot Juneja, Matthew Law, Robin Huang, Hamish McManus, Mark N. Polizzotto, Rebecca Guy, Peter Cronin, David A. Cooper, Richard T. Gray
Published 2019-01-01

Correction: expanded HIV pre-exposure prophylaxis (PrEP) implementation in communities in new South Wales, Australia (EPIC-NSW): design of an open label, single arm implementation...

by Iryna B. Zablotska, Christine Selvey, Rebecca Guy, Karen Price, Jo Holden, Heather-Marie Schmidt, Anna McNulty, David Smith, Fengyi Jin, Janaki Amin, David A. Cooper, Andrew E. Grulich, on behalf of the EPIC-NSW study group
Published 2018-02-01

Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing

by David van Bockel, C. Mee Ling Munier, Stuart Turville, Steven G. Badman, Gregory Walker, Alberto Ospina Stella, Anupriya Aggarwal, Malinna Yeang, Anna Condylios, Anthony D. Kelleher, Tanya L. Applegate, Andrew Vallely, David Whiley, William Rawlinson, Phillip Cunningham, John Kaldor, Rebecca Guy
Published 2020-10-01

Merging Australia's national HIV and AIDS registries: improving quality and completeness of data

by Tarana T.A. Lucky, Ann M. McDonald, Handan Wand, Meeyin Lam, Carol El‐Hayek, David P. Wilson
Published 2013-08-01

The longer-term effects of access to HIV self-tests on HIV testing frequency in high-risk gay and bisexual men: follow-up data from a randomised controlled trial

by Ye Zhang, Mph, Muhammad S Jamil, PhD, Kirsty S Smith, PhD, Tanya L Applegate, PhD, Garrett Prestage, PhD., Martin Holt, PhD, Phillip Keen, BA, Benjamin R Bavinton, PhD, Marcus Chen, PhD, Damian P Conway, PhD, Handan Wand, PhD, Anna M McNulty, MMed, Darren Russell, PhD, Matthew Vaughan, MS, Colin Batrouney, BA, Virginia Wiseman, PhD, Christopher K Fairley, PhD, Andrew E Grulich, PhD, Matthew Law, PhD, John M Kaldor, PhD, Rebecca J Guy, PhD
Published 2021-09-01

Understanding the Determinants of BnAb Induction in Acute HCV Infection

by Alexander P. Underwood, Melanie R. Walker, Nicholas A. Brasher, Auda A. Eltahla, Lisa Maher, Fabio Luciani, Andrew R. Lloyd, Rowena A. Bull
Published 2018-11-01

The effectiveness of non-pharmaceutical interventions on outbreaks of COVID-19 in aged care and long-term care facilities: A meta-analysis

by Princy Poovanna Natolanda, Ashley Quigley, Aye Moa, Chandini Raina MacIntyre
Published 2021-07-01

O9 Progress towards elimination: rapid uptake of HCV treatment among people who inject drugs following broad access to DAA therapies

by J. Iversen, J. Grebely, B. Catlett, P. Cunningham, G.D. Dore, L. Maher
Published 2017-08-01

Novel RNA Duplex Locks HIV-1 in a Latent State via Chromatin-mediated Transcriptional Silencing

by Chantelle Ahlenstiel, Catalina Mendez, Steven T H Lim, Katherine Marks, Stuart Turville, David A Cooper, Anthony D Kelleher, Kazuo Suzuki
Published 2015-01-01

Modular Lentiviral Vectors for Highly Efficient Transgene Expression in Resting Immune Cells

by Christina Fichter, Anupriya Aggarwal, Andrew Kam Ho Wong, Samantha McAllery, Vennila Mathivanan, Bailey Hao, Hugh MacRae, Melissa J. Churchill, Paul R. Gorry, Michael Roche, Lachlan R. Gray, Stuart Turville
Published 2021-06-01